Drug Ther Bull. 2010 Oct;48(10):113-6. doi: 10.1136/dtb.2010.10.0052.
Earlier this year, tamsulosin, an alpha blocker previously only available on prescription, became available for sale by pharmacists as a treatment for functional symptoms of benign prostatic hyperplasia (BPH) in men aged 45-75 years (Flomax Relief MR - Boehringer Ingelheim). A television advert for the over-the-counter (OTC) product claims that it is a "simple and effective" treatment that can relieve symptoms within 1 week, allowing the user to "take control of your annoying pee problems".¹ Here we review the evidence on tamsulosin and assess whether its availability as an OTC product confers worthwhile advantages.
今年早些时候,坦索罗辛这种以前只能凭处方购买的α受体阻滞剂,开始可供药剂师销售,用于治疗45至75岁男性良性前列腺增生(BPH)的功能性症状(可多华缓释片 - 勃林格殷格翰公司)。一则关于这种非处方药(OTC)产品的电视广告宣称,它是一种“简单有效的”治疗方法,能在1周内缓解症状,让使用者“掌控恼人的排尿问题”。¹ 在此,我们回顾关于坦索罗辛的证据,并评估其作为非处方药供应是否具有值得的优势。